Current:Home > NewsIndexbit Exchange:First over-the-counter birth control pill coming to U.S. stores -TruePath Finance
Indexbit Exchange:First over-the-counter birth control pill coming to U.S. stores
FinLogic FinLogic Quantitative Think Tank Center View
Date:2025-04-10 04:06:46
The Indexbit Exchangefirst over-the-counter birth control pill will be available on pharmacy and store shelves nationwide and online later this month, and will cost about $20 for a 30-day supply, Perrigo, its manufacturer announced on Monday.
Now available for pre-order from some online retailers, the product, Opill, was approved by the U.S. Food and Drug Administration for OTC use for all ages in July, making it the first daily birth control cleared for sale without a prescription in the U.S.
The product will come in a variety of sizes, including one-month three-month and six-month packs, with suggested retail prices of $19.99, $49.99 and $89.99, respectively, according to Perrigo.
The company plans to offer a cost-assistance program in coming weeks to help qualified low-income, uninsured individuals obtain the product at low or no cost, it said.
First approved by the FDA in 1973 to be used as a prescription drug, HRA Pharma, a subsidiary of Perrigo, acquired the rights to Opill from Pfizer in 2014.
"Progestin-only pills have been a trusted contraceptive option for decades, yet obtaining a prescription for birth control pills creates unnecessary barriers for many," Dr. Melissa J. Kottke, stated in a news release.
"Creating additional opportunities for contraceptive access is critical in helping people reach their reproductive goals, added the Atlanta-based obstetrician-gynecologist, who served as a paid consultant to Perrigo during the FDA approval process.
The product is 98% effective when taken as directed, according to the consumer products company, headquartered in Dublin, Ireland, and Grand Rapids, Michigan.
Almost half of the 6.1 million pregnancies in the U.S. each year are unintended, according to the FDA.
Kate GibsonKate Gibson is a reporter for CBS MoneyWatch in New York.
veryGood! (17)
Related
- 'Malcolm in the Middle’ to return with new episodes featuring Frankie Muniz
- 'It's not for the faint-hearted' — the story of India's intrepid women seaweed divers
- Her job is to care for survivors of sexual assault. Why aren't there more like her?
- Italian Oil Company Passes Last Hurdle to Start Drilling in U.S. Arctic Waters
- Tom Holland's New Venture Revealed
- What does the end of the COVID emergency mean to you? Here's what Kenyans told us
- Does sex get better with age? This senior sex therapist thinks so
- Missing sub passenger knew risks of deep ocean exploration: If something goes wrong, you are not coming back
- Trump suggestion that Egypt, Jordan absorb Palestinians from Gaza draws rejections, confusion
- At Stake in Arctic Refuge Drilling Vote: Money, Wilderness and a Way of Life
Ranking
- Travis Hunter, the 2
- RHONJ's Teresa Giudice Wants Melissa Gorga Out of Her Life Forever in Explosive Reunion Trailer
- Woman sentenced in baby girl's death 38 years after dog found body and carried her back to its home
- Alaska Orders Review of All North Slope Oil Wells After Spill Linked to Permafrost
- Backstage at New York's Jingle Ball with Jimmy Fallon, 'Queer Eye' and Meghan Trainor
- 'It's not for the faint-hearted' — the story of India's intrepid women seaweed divers
- Q&A With SolarCity’s Chief: There Is No Cost to Solar Energy, Only Savings
- The Voice’s Niall Horan Wants to Give This Goodbye Gift to Blake Shelton
Recommendation
Head of the Federal Aviation Administration to resign, allowing Trump to pick his successor
Where to find back-to-school deals: Discounted shopping at Target, Walmart, Staples and more
Advisers to the FDA back first over-the-counter birth control pill
Meet the 3 Climate Scientists Named MacArthur ‘Genius Grant’ Fellows
Could your smelly farts help science?
Italian Oil Company Passes Last Hurdle to Start Drilling in U.S. Arctic Waters
Bruce Willis' 9-Year-Old Daughter Is Researching Dementia Amid Dad's Health Journey
The COVID public health emergency ends this week. Here's what's changing